Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InvestiGAIT: Bimagrumab in Sarcopenia
NCT02333331Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2014
- Primary completion
- Jun 2018
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of bimagrumab in Sarcopenia, sponsored by Novartis. Started Dec 2014; status: completed.
02
Drugs
bimagrumab
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT02333331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333331.